Abstract
Research indicates that exposure to microgravity leads to immune system dysregulation. However, there is a lack of clear evidence on the specific reasons and precise mechanisms accounting for these immune system changes. Past studies investigating space travel-induced alterations in immunological parameters report many conflicting results, explained by the role of certain confounders, such as cosmic radiation, individual body environment, or differences in experimental design. To minimize the variability in results and to eliminate some technical challenges, we advocate conducting thorough feasibility studies prior to actual suborbital or orbital space experiments. We show how exposure to suborbital flight stressors and the use of a two-dimensional slow rotating device affect T-cells and cancer cells survivability. To enhance T-cell activation and viability, we primed them alone or in combination with IL-2 and IL-12 cytokines. Viability of T-cells was assessed before, during the experiment, and at the end of the experiment for which T-cells were counted every day for the last 4 days to allow the cells to form clear structures and do not disturb their evolution into various geometries. The slow rotating device could be considered a good system to perform T-cell activation studies and develop cell aggregates for various types of cells that react differently to thermal stressors.
Original language | American English |
---|---|
Journal | Gravitational and Space Research |
Volume | 7 |
DOIs | |
State | Published - Oct 10 2019 |
Keywords
- Suborbital flight • cell biology • Blue Origin • New Shepard • Sensors • Microgravity • T-cells • Cytokines • Cancer cells • Cell aggregates
Disciplines
- Aviation and Space Education
- Biological Engineering
- Molecular, Cellular, and Tissue Engineering
- Cell Biology
- Animal Experimentation and Research
- Translational Medical Research